|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes显示文摘 | Bo Ahrén Anja Schweizer Sylvie Dejager Beth E. Dunning Peter M. Nilsson Margaretha Persson James E. Foley | 2009 | The Journal of Clinical Endocrinology & Metabolism2009，，4： | 3 |
| 2 | Efficacy and tolerability of vildagliptin monotherapy in drug-na?ve patients with type 2 diabetes显示文摘 | F. Xavier Pi-Sunyer Anja Schweizer David Mills Sylvie Dejager | 2007 | Diabetes Research and Clinical Practice2007，，1： | 2 |
| 3 | Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes 显示文摘 | Ahron B Schweizer A Dejager S | 2009 | J Clin Endocrinol Metab2009，94，： | 1 |
| 4 | Assessing the general safety and tolerability of vildagliptin:value of pooled analyses from a large safety database versus evaluation of individual studies显示文摘 | Schweizer A Dejager S Foley J E | 2011 | Vasc Health Risk Manag2011，7，： | 1 |
| 5 | Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride,with no weight gain:results from a 2-year study显示文摘 | Matthews DR Dejager S Ahren B | | 0，，： | 1 |
| 6 | Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial显示文摘 | Rosenstock J Baron MA Dejager S | 2007 | Diabetes Care2007，30，2： | 1 |
| 7 | Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes 显示文摘 | Ahr6n B Schweizer A Dejager S | 2009 | J Clin Endoerinol Melab2009，94，4： | 1 |
| 8 | Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes:a 24-week,double-blind,randomized trial显示文摘 | Schweizer A Dejager S Bosi E | 2009 | Diabetes Obes Metab2009，11，8： | 1 |
| 9 | Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared w ith glimepiride,w ith no w eight gain:results from a 2-year study显示文摘 | Matthews DR Dejager S Ahren B | 2010 | Diabetes Obes M etab2010，12，： | 1 |
| 10 | Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study 显示文摘 | Bruckert E Hayem G Dejager S | 2005 | Cardiovasc Drugs Ther2005，19，6： | 1 |
| 11 | Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes显示文摘 | Ahren B Schweizer A Dejager S | 2009 | J Clin Endocrinol Metab2009，94，4： | 1 |
| 12 | Vildagliptin in drug-naive patients with type 2 diabetes: A 24-week, double-blind, randomized, placebo-controlled, multiple-dose study 显示文摘 | Dejager S Razac S Foley JE | 2007 | Horm Metab Res2007，39，3： | 1 |
| 13 | Vildagliptin add-on to mefformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride,with no weight gain:results from a 2-year study显示文摘 | Matthews D R Dejager S Ahren B | 2010 | Diabetes Obes Metab2010，12，9： | 1 |
| 14 | Type I interferon drives tumor necrosis factor-induced lethal shock显示文摘 | Huys L Van Hauwermeiren F Dejager L | 2009 | J Exp Med2009，206，9： | 1 |
| 15 | Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans显示文摘 | Ahrén B Schweizer A Dejager S | 2011 | Diabetes Obes Metab2011，13，： | 1 |
| 16 | Mechanisms of action of the dipeptidyl peptidase4 inhibitor vildagliptin in humans显示文摘 | Ahr6n B Schweizer A Dejager S | 2011 | Diabetes Obes Metab2011，13，9： | 1 |
| 17 | Mechanisms of actionof the dipeptidyl peptidase-4 inhibitor vildagliptin in humans 显示文摘 | Ahr^n B Schweizer A Dejager S | 2011 | Diabetes Obes Metab2011，13，9： | 1 |
| 18 | The theory of singular perturbations显示文摘 | Dejager E M Jiang Fu-ru | 1996 | Applied Mathematics and Mechanics1996，，： | 1 |
| 19 | Continuous delta modulation 显示文摘 | GREEFLES J A DEJAGER F | 1968 | Philips Res Rep1968，23，2： | 1 |
| 20 | Comparison of vildagliptin andmetformin monotherapy in elderly patients with type 2 diabetes:a24-week,double-blind,randomized trial显示文摘 | Schweizer A Dejager S Bosi E | 2009 | Diabetes Obes Metab2009，11，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员